A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection

NCT06635798 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

582

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus

Interventions

BIOLOGICAL: GR2001
BIOLOGICAL: HTIG

Sponsor

Genrix (Shanghai) Biopharmaceutical Co., Ltd.